Company: MDCXW
Filing Date: 2025-05-27
Form Type: S-1
Source: 0001062993-25-010333
Chunk: 250

Company: Medicus Pharma Ltd.
Filing Date: 2025-05-27
Form: S-1
Chunk 250
---
 Company of debentures (the "Debentures") issuable in an aggregate principal amount of up to $5,000,000 (the "Subscription Amount"). Yorkville purchased and the Company issued $1,250,000 in aggregate principal amount of Debentures upon the signing of the Purchase Agreement, for net proceeds to the company of $1,125,000. An additional $3,750,000 is available to the Company in accordance with the Purchase Agreement at the Company's election and upon the achievement of certain triggers. The Debenture is guaranteed by each of the Company's subsidiaries pursuant to a global guaranty agreement. Interest will accrue on the outstanding principal amount of each Debenture at an annual rate of 8.00%, subject to a potential increase to 18.00% per annum upon the occurrence of certain events of default. The Debentures will mature on February 2, 2026.

<div align='center'>F-40

Up to 3,710,000 Common Shares

MEDICUS PHARMA LTD.

PRELIMINARY PROSPECTUS

, 2025

PART II
INFORMATION NOT REQUIRED IN PROSPECTUS</div>

Item 13. Other Expenses of Issuance and Distribution

Set forth below is an itemization of the total expenses, excluding underwriting discounts and commissions, if any, which are expected to be incurred in connection with the sale of the securities being registered. With the exception of the registration fee payable to the SEC, all amounts are estimates.

| Itemized expenses               |     |   |  Amount |
|:--------------------------------|:----|:--|--------:|
| SEC Registration Fee            |     | $ |   4,350 |
| Printing expenses               |     |   |  15,000 |
| Legal fees and expenses         |     |   | 125,000 |
| Accounting fees and expenses    |     |   |  30,000 |
| Miscellaneous fees and expenses |     |   |  25,650 |
| Total                           |     | $ | 200,000 |

Item 14. Indemnification of Directors and Officers

Under the Business Corporations Act (Ontario), or the OBCA, the registrant may indemnify a present or former director or officer or a person who acts or acted at the registrant's request as a director or officer, or an individual acting in a similar capacity, of another entity,